These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15864219)
1. Primary stenting of occluded native coronary arteries II--rationale and design of the PRISON II study: a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of chronic total coronary occlusions. Rahel BM; Laarman GJ; Suttorp MJ; Am Heart J; 2005 Mar; 149(3):e1-3. PubMed ID: 15864219 [TBL] [Abstract][Full Text] [Related]
2. A randomized comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions: rationale and design of the PRImary Stenting of Occluded Native coronary arteries III (PRISON III) study. Suttorp MJ; Laarman GJ; Am Heart J; 2007 Sep; 154(3):432-5. PubMed ID: 17719285 [TBL] [Abstract][Full Text] [Related]
3. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Suttorp MJ; Laarman GJ; Rahel BM; Kelder JC; Bosschaert MA; Kiemeneij F; Ten Berg JM; Bal ET; Rensing BJ; Eefting FD; Mast EG Circulation; 2006 Aug; 114(9):921-8. PubMed ID: 16908768 [TBL] [Abstract][Full Text] [Related]
4. Sirolimus-eluting stent in chronic total occlusion: the SICTO study. Lotan C; Almagor Y; Kuiper K; Suttorp MJ; Wijns W J Interv Cardiol; 2006 Aug; 19(4):307-12. PubMed ID: 16881976 [TBL] [Abstract][Full Text] [Related]
5. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise? Jensen J; Lagerqvist B; Aasa M; Särev T; Nilsson T; Tornvall P J Intern Med; 2006 Aug; 260(2):118-24. PubMed ID: 16882275 [TBL] [Abstract][Full Text] [Related]
6. Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting. Lemos PA; Mercado N; van Domburg RT; Kuntz RE; O'Neill WW; Serruys PW Circulation; 2004 Nov; 110(20):3199-205. PubMed ID: 15505082 [TBL] [Abstract][Full Text] [Related]
7. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A; JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543 [TBL] [Abstract][Full Text] [Related]
8. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited. Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613 [TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA; JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619 [TBL] [Abstract][Full Text] [Related]
10. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524 [TBL] [Abstract][Full Text] [Related]
11. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions. Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408 [TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Popma JJ; Leon MB; Moses JW; Holmes DR; Cox N; Fitzpatrick M; Douglas J; Lambert C; Mooney M; Yakubov S; Kuntz RE; Circulation; 2004 Dec; 110(25):3773-80. PubMed ID: 15596568 [TBL] [Abstract][Full Text] [Related]
13. Comparison of thrombosis and restenosis risk from stent length of sirolimus-eluting stents versus bare metal stents. Mauri L; O'Malley AJ; Popma JJ; Moses JW; Leon MB; Holmes DR; Teirstein PS; Cutlip DE; Donahoe D; Kuntz RE Am J Cardiol; 2005 May; 95(10):1140-5. PubMed ID: 15877983 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C; Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930 [TBL] [Abstract][Full Text] [Related]
15. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study). Rahel BM; Laarman GJ; Kelder JC; Ten Berg JM; Suttorp MJ Am Heart J; 2009 Jan; 157(1):149-55. PubMed ID: 19081412 [TBL] [Abstract][Full Text] [Related]
16. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. van Hout BA; Serruys PW; Lemos PA; van den Brand MJ; van Es GA; Lindeboom WK; Morice MC Heart; 2005 Apr; 91(4):507-12. PubMed ID: 15772214 [TBL] [Abstract][Full Text] [Related]
17. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP; JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102 [TBL] [Abstract][Full Text] [Related]
18. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). Van den Branden BJ; Rahel BM; Laarman GJ; Slagboom T; Kelder JC; Ten Berg JM; Suttorp MJ EuroIntervention; 2012 Feb; 7(10):1189-96. PubMed ID: 22030323 [TBL] [Abstract][Full Text] [Related]